USFDA closes observations on Granules India's arm

摘要

The US Food and Drug Administration (USFDA) has closed its observations on Granules Pharmaceuticals Ine (GPI), a wholly-owned foreign subsidiary of Granules India Ltd. in Chantilly, Virginia, USA.